Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
December 17, 2009
Fluorescence labeling of intracellular antigens of attached or suspended tissue-culture cells
Mark C Willingham
Methods in Molecular Biology (Clifton, N.J.)
|
December 17, 2009
Fluorescence labeling of surface antigens of attached or suspended tissue-culture cells
Mark C Willingham
Cancer Immunology, Immunotherapy : CII
|
January 20, 2004
The effect of aging on cellular immunity against cancer in SR/CR mice
Zheng Cui, Mark C Willingham
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
March 19, 2002
Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3
Allen M Gown, Mark C Willingham
Thyroid : Official Journal of the American Thyroid Association
|
December 20, 2002
Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis
Hideyo Suzuki, Mark C Willingham, Sheue-Yann Cheng
Journal of Virology
|
April 1, 2011
Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo
Zachary D Cary, Mark C Willingham, Douglas S Lyles
The Journal of Steroid Biochemistry and Molecular Biology
|
July 1, 2004
19-Nor-1alpha,25-dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations
István Molnár, Timothy Kute, Mark C Willingham, et al.
Carcinogenesis
|
July 31, 2007
Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer
Fumihiko Furuya, Changxue Lu, Mark C Willingham, et al.
Endocrinology
|
July 3, 2004
A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis
Yasuhito Kato, Hao Ying, Mark C Willingham, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
August 6, 2005
Localization of mesothelin in epithelial ovarian cancer
Raffit Hassan, Robert J Kreitman, Ira Pastan, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
Methods in Molecular Biology (Clifton, N.J.)
|
December 17, 2009
Fluorescence labeling of intracellular antigens of attached or suspended tissue-culture cells
Mark C Willingham
Methods in Molecular Biology (Clifton, N.J.)
|
December 17, 2009
Fluorescence labeling of surface antigens of attached or suspended tissue-culture cells
Mark C Willingham
Cancer Immunology, Immunotherapy : CII
|
January 20, 2004
The effect of aging on cellular immunity against cancer in SR/CR mice
Zheng Cui, Mark C Willingham
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
March 19, 2002
Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3
Allen M Gown, Mark C Willingham
Thyroid : Official Journal of the American Thyroid Association
|
December 20, 2002
Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis
Hideyo Suzuki, Mark C Willingham, Sheue-Yann Cheng
Journal of Virology
|
April 1, 2011
Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo
Zachary D Cary, Mark C Willingham, Douglas S Lyles
The Journal of Steroid Biochemistry and Molecular Biology
|
July 1, 2004
19-Nor-1alpha,25-dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations
István Molnár, Timothy Kute, Mark C Willingham, et al.
Carcinogenesis
|
July 31, 2007
Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer
Fumihiko Furuya, Changxue Lu, Mark C Willingham, et al.
Endocrinology
|
July 3, 2004
A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis
Yasuhito Kato, Hao Ying, Mark C Willingham, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
August 6, 2005
Localization of mesothelin in epithelial ovarian cancer
Raffit Hassan, Robert J Kreitman, Ira Pastan, et al.
Page
of 10